EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC-ND 4.0

Pharmacology and relevant drug interactions of metamizole

David J Brinkman iD, Linda C Hendriksen, Irma M Rigter, Markus W Hollmann

British Journal of Clinical Pharmacology · 2025-07 · 91 (7) · 2095-2102

DOI: 10.1002/bcp.70101 ↗

At a glance

Übersichtsarbeit in British Journal of Clinical Pharmacology, published online on 2025-05-15. Written by David J Brinkman and 3 co-authors. Institution: Department of Anaesthesiology, Amsterdam UMC, Amsterdam, Netherlands. Major MEDLINE topics: Dipyrone, Anti-Inflammatory Agents, Non-Steroidal. Cited 12 times so far (Crossref); 38 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Metamizole is a frequently prescribed analgesic because of its favourable benefit/risk ratio compared with classic NSAIDs. However, increasing research shows that metamizole displays several drug interactions that are relevant to clinical practice. We reviewed the literature to summarize the pharmacology and most clinically relevant drug interactions of metamizole. Metamizole has a fast analgesic effect but a short half‐life and duration of action. The exact mechanism of action of metamizole is currently not fully known. Studies showed that metamizole appears to be a moderate to strong inductor of the enzymes CYP3A4, CYP2B6 and CYP2C19; a weak inductor of CYP2C9; and a moderate inhibitor of CYP1A2. Furthermore, metamizole inhibits the effect of acetylsalicylic acid when taken simultaneously. Metamizole should be cautiously used together with other drugs that can cause agranulocytosis. If metamizole is prescribed in a high dosage (1000 mg three or four times daily) for more than 1 day, these pharmacokinetic and dynamic interactions should be taken into account.

Subjects

MeSH terms (MEDLINE)

DipyroneAnti-Inflammatory Agents, Non-SteroidalHumansDrug InteractionsCytochrome P-450 Enzyme SystemAspirin

Author keywords

CYPacetylsalicylic aciddipyroneinteractionsmetamizolepharmacology

Substances

DipyroneAnti-Inflammatory Agents, Non-SteroidalCytochrome P-450 Enzyme SystemAspirin

Authors and institutions

  • Department of Anaesthesiology, Amsterdam UMC, Amsterdam, Netherlands.
  • Department of Internal Medicine, Pharmacotherapy Unit, Amsterdam UMC, Amsterdam, Netherlands.
  • Research and Expertise Centre in Pharmacotherapy Education (RECIPE), Amsterdam, Netherlands.
  • Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC, Amsterdam, Netherlands.

ORCID profiles: David J Brinkman

Cite

APA

Brinkman, D. J., Hendriksen, L. C., Rigter, I. M., & Hollmann, M. W. (2025). Pharmacology and relevant drug interactions of metamizole. British Journal of Clinical Pharmacology, 91(7), 2095-2102. https://doi.org/10.1002/bcp.70101

Vancouver

Brinkman DJ, Hendriksen LC, Rigter IM, Hollmann MW. Pharmacology and relevant drug interactions of metamizole. British Journal of Clinical Pharmacology. 2025;91(7):2095-2102. doi:10.1002/bcp.70101

BibTeX
@article{Brinkman2025,
  author = {Brinkman, David J and Hendriksen, Linda C and Rigter, Irma M and Hollmann, Markus W},
  title = {Pharmacology and relevant drug interactions of metamizole},
  journal = {British Journal of Clinical Pharmacology},
  year = {2025},
  volume = {91},
  number = {7},
  pages = {2095--2102},
  doi = {10.1002/bcp.70101}
}
Start for free →